Excellus BCBS Partnering With Civica To Increase Access To Affordable Insulin
Issued March 29, 2022
Excellus BlueCross BlueShield, the Blue Cross Blue Shield Association (BCBSA) and other Blue Cross and Blue Shield (BCBS) companies joined Civica’s initiative to manufacture and distribute affordable insulins that, once approved, will be available to people living with diabetes at significantly lower prices than insulins currently on the market. The medications are expected to be available to all consumers for $30 or less per vial starting in 2024.
Script for Excellus BCBS Employer/Broker News Archive/Article